Magic mushroom therapy tested for End-of-Life distress
NCT ID NCT04950608
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether psilocybin (the active ingredient in magic mushrooms) combined with talk therapy could help reduce feelings of demoralization in people receiving hospice care. Fifteen terminally ill adults participated. The main goal was to see if the approach was practical and acceptable, not to prove it works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER TERMINAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Care Dimensions
Danvers, Massachusetts, 01923, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can magnetic pulses to the brain calm End-of-Life distress?
- Bringing the gym to the farm: could a tailored home workout beat cancer fatigue?
- Psychedelic therapy aims to break the relapse cycle in alcoholism and depression
- Can a scented fan ease breathlessness at the end of life?
- Can a helping hand improve medical decisions for underserved patients?
- Inner strength boosts morale in elderly cancer patients